The antihypertension drug Blutforde was certified in Spain at the beginning of 2023. The dosage form of the drug is gelatin-coated capsules intended for oral administration by adults. Capsules in the amount of 20 pieces are packed in a plastic bottle and a cardboard box. The kit contains instructions for use, including a section with contraindications. Be sure to read these instructions before using capsules.
Blutforde capsules have a concentrated composition with active ingredients that tend to accumulate in the body. To achieve the best result, you must take the drug without interruption for 30 days. If necessary, the admission period can be extended to 60 days. You must take the capsules twice a day, the recommended time is morning and evening after meals. It is advisable to allow approximately 6-8 hours between doses. The capsules are washed down with clean water without gas, on average 100-150 ml of water is required. The gelatin shell begins to dissolve in the stomach, after which the components of the composition are absorbed and enter the circulatory system. Do not take two capsules at the same time. Although no side effects or allergic reactions have been observed, exceeding the recommended dose may cause additional stress on the hormonal and excretory systems.
An additional advantage of Blutforde capsules is that they can be used either alone or in combination with other medications. In addition, not only a cure, but also a one-time application is possible, for example to lower blood pressure during stress. You can also drink them to prevent high blood pressure when the first symptoms of high blood pressure appear. In this case, you can drink it once a day for two weeks. This is enough to restore the normal functionality of the cardiovascular system and normalize metabolic processes. Before use, make sure you have any signs of high blood pressure, which may indicate use.
The drug is contraindicated in case of individual intolerance to the components of the composition, in the last trimester and during breastfeeding, in oncological diseases of the gastrointestinal tract and organic lesions of the heart or brain. It is not recommended to be given to children under 12 years old and people over 80 years old.
